文献速递眼底病与葡萄膜炎

ARMS2 A69S 多态性与 AMD 高危眼杆介导暗适应延迟相关

The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration.
PubMed 文献 · Ophthalmology · 2018-10-31

横断面研究纳入 543 名 60 岁以上成人,其中 408 眼黄斑健康、135 例 AMD(多为早期)。在矫正年龄和吸烟后,ARMS2 A69S 与 CFH Y402H 变异均与杆介导暗适应速率变慢(RIT 延长)相关;黄斑健康者中仅 ARMS2 A69S 与 RIT 延长相关。

要点

  • ARMS2 A69S 与 CFH Y402H 均与整体样本 RIT 延长相关。
  • 黄斑健康者中 ARMS2 A69S 与 RIT 延长相关,CFH Y402H 不相关。
  • AMD 患者中 ARMS2 A69S 与 CFH Y402H 均与 RIT 延长相关。

核心结论

  • 携带高风险 ARMS2 和 CFH 基因型的老年人更易表现为杆介导暗适应延迟。
  • 在 AMD 临床表型出现前,黄斑健康但携带 ARMS2 A69S 等位基因者已显示暗适应延迟。

研究设计与样本

  • 横断面研究,纳入 60 岁及以上成人,黄斑健康定义为双眼 AREDS 9 步分类第 1 步,AMD 定义为第 2–9 步。
  • 采用 Taqman 法对 CFH 和 ARMS2 基因单核苷酸多态性进行基因分型。
  • 在光漂白后于下垂直子午线 5° 处评估单眼杆介导暗适应,以杆截距时间(RIT)定义暗适应速率。
  • 样本共 543 名参与者同时具有基因型和 RIT 测定,其中 408 例黄斑健康、135 例 AMD(124 例为早期 AMD)。

主要发现

  • 整体样本中,ARMS2 A69S 与 RIT 延长相关(校正 P=0.0001),CFH Y402H 亦与 RIT 延长相关(校正 P=0.0023)。
  • 黄斑健康参与者中,ARMS2 A69S 与 RIT 延长相关(校正 P=0.0011),CFH Y402H 不相关(校正 P=0.2175)。
  • AMD 患者中,ARMS2 A69S 与 RIT 延长相关(校正 P=0.0182),CFH Y402H 亦相关(校正 P=0.0222)。
  • 携带更多高风险 ARMS2 和 CFH 等位基因者在健康组和 AMD 组均显示更高 RIT(校正 P=0.0002 和 P<0.0001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To examine the association between sequence variants in genetic risk factors for age-related macular degeneration (AMD) and delayed rod-mediated dark adaptation (RMDA), the first functional biomarker for incident AMD, in older adults with normal macular health and early AMD. DESIGN: Cross-sectional. PARTICIPANTS: Adults 60 years of age or older showing normal macular health (defined as both eyes at step 1 on the Age-Related Eye Disease Study 9-step AMD classification system) and those with AMD in one or both eyes (defined as steps 2-9). METHODS: Single nucleotide polymorphisms were genotyped in the complement factor H (CFH) and ARMS2 genes using a Taqman assay. Rod-mediated dark adaptation was assessed in 1 eye after photobleach with targets centered at 5° on the inferior vertical meridian. Rate of dark adaptation was defined by rod intercept time (RIT), duration (in minutes) required for sensitivity to reach a criterion sensitivity level in the latter half of the second component of rod recovery. Associations between CFH and ARMS2 polymorphisms and RMDA were adjusted for age and smoking. MAIN OUTCOME MEASURE: Rod intercept time. RESULTS: The sample consisted of 543 participants having both genotype and RIT determination; 408 showed normal macular health and 135 demonstrated AMD, most having early AMD (124 of 135). For the combined sample, higher RIT (slower RMDA) was observed for both the A69S variant in ARMS2 and the Y402H variant in CFH (adjusted P = 0.0001 and P = 0.0023, respectively). For healthy participants, the A69S variant in ARMS2 was associated with higher RIT (adjusted P = 0.0011), whereas the Y402H variant in CFH was not (adjusted P = 0.2175). For AMD patients, the A69S variant of ARMS2 and the Y402H variant of CFH were associated with higher RIT (adjusted P = 0.0182 and P = 0.0222, respectively). Those with a larger number of high-risk ARMS2 and CFH alleles showed higher RIT, in both healthy and AMD groups (adjusted P = 0.0002 and P < 0.0001, respectively). CONCLUSIONS: We report a novel association wherein older adults with high-risk ARMS2 and CFH genotypes are more likely to demonstrate delayed RMDA, the first functional biomarker for incident early AMD. Before the AMD clinical phenotype is present, those showing normal macular health with the ARMS2 A69S allele demonstrate delayed RMDA. Understanding ARMS2 function is a research priority.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Mullins RF, McGwin G, Searcey K, et al. The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration. Ophthalmology. 2018. PMID: 30389424. doi:10.1016/j.ophtha.2018.10.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。